Domenico Levato

1.3k total citations
29 papers, 974 citations indexed

About

Domenico Levato is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Domenico Levato has authored 29 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 22 papers in Pathology and Forensic Medicine and 12 papers in Immunology. Recurrent topics in Domenico Levato's work include Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (22 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Domenico Levato is often cited by papers focused on Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (22 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Domenico Levato collaborates with scholars based in Italy and United States. Domenico Levato's co-authors include Stefano Molica, Gaetano Vitelli, A Dattilo, Luciano Levato, G.M. Gandolfo, Pellegrino Musto, Vincenzo Liso, S. Molica, Angelo Vacca and Doménico Ribatti and has published in prestigious journals such as Blood, Cancer and British Journal of Cancer.

In The Last Decade

Domenico Levato

29 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Domenico Levato Italy 20 674 461 387 309 205 29 974
Daniela Gottardi Italy 11 605 0.9× 379 0.8× 405 1.0× 353 1.1× 120 0.6× 19 1.0k
Rémi Letestu France 18 680 1.0× 536 1.2× 374 1.0× 211 0.7× 399 1.9× 52 1.1k
Marwan Kwok United Kingdom 10 522 0.8× 422 0.9× 277 0.7× 320 1.0× 122 0.6× 15 881
Claudia Fazi Italy 12 583 0.9× 397 0.9× 368 1.0× 192 0.6× 172 0.8× 20 804
Timothy J. Murphy United States 9 778 1.2× 799 1.7× 399 1.0× 192 0.6× 158 0.8× 19 1.2k
Marie‐José Rapp France 6 360 0.5× 287 0.6× 159 0.4× 289 0.9× 371 1.8× 7 720
Claire Dearden United Kingdom 9 531 0.8× 369 0.8× 160 0.4× 157 0.5× 378 1.8× 16 947
John N. Allan United States 21 803 1.2× 708 1.5× 319 0.8× 206 0.7× 286 1.4× 97 1.1k
Daniel Heintel Austria 13 346 0.5× 289 0.6× 168 0.4× 442 1.4× 322 1.6× 30 846
Till Seiler Germany 11 1000 1.5× 757 1.6× 588 1.5× 196 0.6× 150 0.7× 19 1.1k

Countries citing papers authored by Domenico Levato

Since Specialization
Citations

This map shows the geographic impact of Domenico Levato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Domenico Levato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Domenico Levato more than expected).

Fields of papers citing papers by Domenico Levato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Domenico Levato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Domenico Levato. The network helps show where Domenico Levato may publish in the future.

Co-authorship network of co-authors of Domenico Levato

This figure shows the co-authorship network connecting the top 25 collaborators of Domenico Levato. A scholar is included among the top collaborators of Domenico Levato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Domenico Levato. Domenico Levato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molica, Stefano, et al.. (2018). A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients. Leukemia & lymphoma. 60(3). 845–847. 12 indexed citations
2.
3.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, et al.. (2004). Serum angiogenin is not elevated in patients with early B‐cell chronic lymphocytic leukemia but is prognostic factor for disease progression. European Journal Of Haematology. 73(1). 36–42. 24 indexed citations
4.
Molica, Stefano, Angelo Vacca, Domenico Levato, Francesca Merchionne, & Doménico Ribatti. (2003). Angiogenesis in acute and chronic lymphocytic leukemia. Leukemia Research. 28(4). 321–324. 30 indexed citations
5.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, et al.. (2003). Increased serum levels of matrix metalloproteinase‐9 predict clinical outcome of patients with early B‐cell chronic lymphocytic leukaemia. European Journal Of Haematology. 70(6). 373–378. 44 indexed citations
6.
7.
Molica, Stefano, Angelo Vacca, Doménico Ribatti, et al.. (2002). Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood. 100(9). 3344–3351. 91 indexed citations
8.
Molica, S., Gaetano Vitelli, Domenico Levato, Diana Giannarelli, & G.M. Gandolfo. (2001). Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Cancer. 92(4). 713–719. 30 indexed citations
9.
Callea, Vincenzo, Fortunato Morabito, Bianca Oliva, et al.. (1999). Surface CD14 positivity in B‐cell chronic lymphocytic leukaemia is related to clinical outcome. British Journal of Haematology. 107(2). 347–352. 10 indexed citations
10.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, G.M. Gandolfo, & Vincenzo Liso. (1999). Increased serum levels of vascular endothelial growth factor predict risk of progression in early B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 107(3). 605–610. 118 indexed citations
11.
Molica, Stefano, Domenico Levato, Nicola Cascavilla, Luciano Levato, & Pellegrino Musto. (1999). Clinico‐prognostic implications of simultaneous increased serum levels of soluble CD23 and β2‐microglobulin in B‐cell chronic lymphocytic leukemia. European Journal Of Haematology. 62(2). 117–122. 74 indexed citations
12.
Stelitano, Caterina, Fortunato Morabito, Vincenzo Callea, et al.. (1999). Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.. PubMed. 84(4). 317–23. 13 indexed citations
13.
Molica, Stefano, Domenico Levato, & A Dattilo. (1999). Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.. PubMed. 84(12). 1094–9. 21 indexed citations
14.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, et al.. (1999). Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.. PubMed. 84(3). 208–11. 36 indexed citations
15.
16.
Molica, Stefano, Gaetano Vitelli, Domenico Levato, et al.. (1998). CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.. PubMed. 83(5). 398–402. 19 indexed citations
17.
Molica, S., et al.. (1996). Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia.. PubMed. 10(5). 907–8. 20 indexed citations
18.
19.
Callea, Vincenzo, et al.. (1994). Comparison of younger versus older B‐cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases. European Journal Of Haematology. 52(4). 216–221. 26 indexed citations
20.
Molica, S., Domenico Levato, & Luciano Levato. (1993). Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up.. PubMed. 78(6). 374–7. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Gottardi Breakdown of academic impact, for papers by Rémi Letestu Breakdown of academic impact, for papers by Marwan Kwok Breakdown of academic impact, for papers by Claudia Fazi Breakdown of academic impact, for papers by Timothy J. Murphy Breakdown of academic impact, for papers by Marie‐José Rapp Breakdown of academic impact, for papers by Claire Dearden Breakdown of academic impact, for papers by John N. Allan Breakdown of academic impact, for papers by Daniel Heintel Breakdown of academic impact, for papers by Till Seiler
Rankless by CCL
2026